Georgia Cancer Specialists-Northside

Atlanta, Georgia 30342

0 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Breast Cancer, Breast Neoplasms, Colorectal Cancer, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Stomach Neoplasms, Triple Negative Breast Neoplasms

Studies at this site

• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy — Stopped early
• A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer — Completed
• FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer — Completed